Note: Please read our disclaimer at the bottom of the article.
#StrongHands 🙌 #BOP 🚀 Nation Update ️️️️️️️️️️️️️️️️️️️❤️️
Hi, I’m Paul Mampilly.
Welcome to my company's Substack, where we provide daily coverage of #OGI (opportunity, growth, and innovation) market trends, macro level analysis, and stock picks.
Like our name suggests, at ATG Digital, we go Against the Grain to support everyday people on their investing journeys.
ATG also represents seeing the world for what is abundantly clear to see — an opportunity for incredible growth and the BRIGHT and PROSPEROUS future that lies ahead.
To aid you on your journey to financial freedom, we have five paid plans starting at $9.99 for you to consider.
With a subscription you get:
Premium Content: Weekly market and stock updates via email newsletter.
Stock Picking Guidance: Flash (buy/sell) alerts with targeted price points.
Model Portfolio Access: Access to LIVE portfolios.
Webinars: Private events with the team based on ideas preselected by you.
(Purple Tier Members)
Just visit atgdigital.media to see which plan is the best fit for your journey!
Substack 🥞 subscribers: 5,777 (+1)
Weekly 🗓 Roundup
Here’s a roundup of all our Substack articles from the week!
If you haven’t had a chance, be sure to check them out here:
Monday — Even Paul Has Never Seen THIS! 😲
Tuesday — This Storage Company Is on Fire 🔥
Wednesday — Generating $800K a Day?! 🤑
Thursday — Is BTC Going to the Moon 🌕 or What?
Today Is the Day! 🙌
Well, it’s finally happening . . .
The Bitcoin USD (BTC-USD) halving is today!
And we want to ring in this crypto holiday with you, ATG Nation. 🥳
So, please tune in for our livestream today at 6:30 p.m. EST! 👇
We hope you’ll join us for this special event! 🎉
P.S. We’re also releasing new merchandise to celebrate the halving today. Be sure to check it out here!
Congratulations, Platinum Tier! 🥳
Today, members of our Platinum Tier had the opportunity to make a double-digit gain on ProShares UltraPro Short QQQ (Nasdaq: QQQ) . . . 👇
If you were able to profit from this, please let us hear from you!
And now, let’s get into Dan’s piece for today . . .
Dan: We’re in This Sector for the Long Haul 💪
Yes, we’re still big on biotech!
Many of these companies are demonstrating massive technological advancements and innovation that will play a significant role in healthcare.
Now, the stock prices of these companies haven’t been bid up yet. But this is all going to change in our opinion . . .
As these revolutionary advances in biotech are priced in, we believe long-term investors will acquire shares, forcing new buyers to bid stock prices far higher.
We hold several biotech companies in our ATG Digital model portfolios. But today, I want to focus on one that could be a massive winner . . .
1 Gold 🏆 Tier Stock to Watch
We hold Dynavax Technologies Corporation (Nasdaq: DVAX) in our Gold Tier model portfolio.
It focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor (TLR) stimulation.
DVAX 0.00%↑'s proprietary technologies, including TLR biology, provide a unique platform for the development of vaccines targeting infectious diseases and cancer.
This platform enables the stimulation of the innate immune system to enhance the body's natural defenses against pathogens and malignant cells.
The cancer vaccine market alone is set to explode to $393 billion by 2032! This is a huge opportunity!
A Significant Opportunity 👀
DVAX 0.00%↑’s pipeline encompasses a diverse range of vaccine candidates targeting infectious diseases, such as hepatitis B and immuno-oncology therapies for the treatment of various cancers.
Notably, the company's lead product, HEPLISAV-B®, is the only two-dose hepatitis B vaccine approved for adults in the U.S.
With a superior immunization schedule and efficacy compared to existing vaccines, HEPLISAV-B® presents a significant commercial opportunity.
Another Promising Product 💉
DVAX 0.00%↑’s immuno-oncology pipeline includes SD-101, a TLR9 agonist being evaluated in combination with checkpoint inhibitors for the treatment of advanced melanoma and other solid tumors.
The synergistic effects of SD-101 with existing immunotherapies hold promise for improving patient outcomes in oncology.
DVAX 0.00%↑ has a current market cap of $1.5 billion. For full-year 2023, it brought in $232.3 million. This gives it a price-to-sales multiple of 6.5X.
But when we look at the growth of DVAX 0.00%↑, the 6.5X multiple still seems low.
Its HEPLISAV-B® vaccine total market share in the U.S. increased to 42% by the end of 2023, compared to 35% in 2022.
Additionally, its net product revenue grew 69% year over year (YoY) to $213.3 million. So, its primary product is on the rise!
As of the end of 2023, DVAX 0.00%↑ holds $742.3 million in cash. That’s nearly 50% of the company’s market cap!
A Bright ☀️ Future
As it expands throughout the U.S., the European Union, and Great Britain, DVAX 0.00%↑’s future looks bright.
This year, the company predicts that its HEPLISAV-B® vaccine will bring in $272.5 million, representing growth of 17% YoY.
Additionally, it also expects to be cash flow positive for the full year. That’s no small feat!
Considering its growing revenue, positive cash flow, strong cash position, and solid balance sheet in a booming sector . . . DVAX 0.00%↑ could be a massive winner!
Biotech & Beyond 🚀
DVAX 0.00%↑ presents us with an incredible opportunity . . . but it’s certainly not the only biotech stock we’re bullish on!
In our Gold Tier model portfolio alone, we hold several biotech companies that we believe have similar potential — not to mention those housed in our other model portfolios.
To get access to them, simply click here and join the ATG Digital family today!
Subscriptions start for as little as $9.99.
#GBC100: Friday, April 19, 2024
The #GBC100 is down 0.06% today.
Created on September 22, 2022, the #GBC100 is an index/portfolio comprised of opportunity, growth, innovation, and crypto-related investments.
Our goals with the #GBC100 are twofold . . .
First, we want readers to get a sense of what our investments are doing in the market, because they can sometimes perform very differently than traditional indices (like the S&P 500 or Nasdaq 100).
Second, we’d like to eventually turn the #GBC100 into an ETF.
That way, instead of owning hundreds of growth stocks, you can get exposure to ATG Digital thinking — in opportunity, growth, innovation, and crypto — all in one place.
To learn more or to express your support for the launch of an ETF (by completing a poll), click here.
New YouTube 📺 Content
Yesterday, Dan released a new video on our YouTube channel . . .
If you haven’t had the chance, be sure to watch it now! 👇
We hope you enjoyed this video! Let us hear from you in the comment section. 👂
Next Week: Paul will cover what’s going on in the crypto world. 🪙 Stay tuned!
Yesterday, Dean wrote a great article about Bitcoin USD (BTC-USD). 🤩
If you haven’t read it yet, be sure to check it out by clicking here!
And look at what one reader had to say:
We love this #BOP (bold, optimistic, positive) attitude! 🚀
On Friday, April 19, 2024, we hope you’ll join us for our BTC halving livestream! 🤗
❤️️ This Substack made — by US, for YOU — with love. ❤️️
Questions? Concerns? 🤔 Look Below 👇
Have questions or trouble accessing your account? Please reach out to us at info@atgdigital.media or schedule a call, and our Customer Support team will be happy to help.
You can also check our FAQ page on our website for an up-to-date list of questions and answers. Your question may have been addressed there.
*Please be advised that customer support calls are limited to 15 minutes and will strictly cover your membership subscription and billing needs only. Any calls that are disrespectful in nature may be subject to immediate termination.
Join us, be #BOP 🚀, be #StrongHands 🙌, #GoATG! ️️❤️️
Disclaimer/Legal Stuff Written in Plain English
What you read/watch/hear is OPINION, not financial/investment advice. Treat it no different than when you read/watch/hear your favorite author/YouTuber/podcaster. Despite our best efforts, we get things wrong and make mistakes. Investing is risky. There is no guarantee you will make money. Your investments may lose value. That’s RISK. Past performance is no guarantee of future results. Employees, contractors, and owners of ATG Digital, LLC own/trade/transact in the stocks, options, and crypto that are the subject of our trade alerts, updates, reports, and commentaries. We cannot give you personalized financial advice because we are NOT financial advisors. It’s on you to decide how much/when/what to buy/sell based on YOUR financial needs, plans, and risk preferences. There are no guarantees. Loss of your capital is an outcome that you should evaluate carefully with a financial advisor before you trade, speculate, or invest. It's your money and your responsibility.